For people living with the unpredictable flares of systemic lupus erythematosus (SLE), a simple, cheap blood test to track the disease would be a game-changer. Researchers looked at whether the neutrophil-to-lymphocyte ratio (NLR)—a calculation from a standard blood count—could be that tool. They analyzed data from 40 studies and validated it with nearly 300 patients from a single center.
The analysis found that, on average, people with lupus do have a higher NLR than healthy people. The ratio was also higher in patients with lupus nephritis (kidney involvement) and during periods of active disease. There was a positive link between the NLR and standard disease activity scores, but it was a weak connection—like a faint signal, not a strong one.
Here's the important catch: the test's accuracy for telling different disease states apart was only modest. Its usefulness also varied significantly based on a patient's ethnicity and what treatments they were on. Because of these limitations, the researchers conclude that the NLR should not be used as a standalone test. It might add some information when combined with other assessments, but it's not ready to be a reliable guide for clinical decisions on its own.
